A Novel Selective Muscarinic Acetylcholine Receptor Subtype 1 Antagonist Reduces Seizures without Impairing Hippocampus-Dependent Learning
Sheffler et al.
Mol. Pharmacol. 2009;76:356-368.
ABSTRACT
| FULL TEXT
Muscarinic Receptor Dependent Long-Term Depression in Rat Visual Cortex Is PKC Independent but Requires ERK1/2 Activation and Protein Synthesis
McCoy and McMahon
J. Neurophysiol. 2007;98:1862-1870.
ABSTRACT
| FULL TEXT
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs
Gilles and Luthringer
J Psychopharmacol 2007;21:272-282.
ABSTRACT
Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects.
Hodges
Brain 2006;129:2811-2822.
ABSTRACT
| FULL TEXT
Sympathetic sprouting drives hippocampal cholinergic reinnervation that prevents loss of a muscarinic receptor-dependent long-term depression at CA3-CA1 synapses.
Scheiderer et al.
J. Neurosci. 2006;26:3745-3756.
ABSTRACT
| FULL TEXT
Cholinergic Inhibition of Neocortical Pyramidal Neurons
Gulledge and Stuart
J. Neurosci. 2005;25:10308-10320.
ABSTRACT
| FULL TEXT
Pharmacological Modulation of Prefrontal Cortical Activity During a Working Memory Task in Young and Older Humans: A PET Study With Physostigmine
Freo et al.
Am. J. Psychiatry 2005;162:2061-2070.
ABSTRACT
| FULL TEXT
A New Visual Scale to Assess White Matter Hyperintensities Within Cholinergic Pathways
Pawlak and Krejza
Stroke 2005;36:2064-2065.
FULL TEXT
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease
Bohnen et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:315-319.
ABSTRACT
| FULL TEXT
Neuropsychological Test Performance in Healthy Volunteers Before and After Donepezil Administration
Beglinger et al.
J Psychopharmacol 2004;18:102-108.
ABSTRACT
Septohippocampal Acetylcholine: Involved in but not Necessary for Learning and Memory?
Parent and Baxter
Learn. Mem. 2004;11:9-20.
ABSTRACT
| FULL TEXT
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam
Learn. Mem. 2004;11:43-49.
ABSTRACT
| FULL TEXT
Cholinergic Modulation of Visual Attention and Working Memory: Dissociable Effects of Basal Forebrain 192-IgG-saporin Lesions and Intraprefrontal Infusions of Scopolamine
Chudasama et al.
Learn. Mem. 2004;11:78-86.
ABSTRACT
| FULL TEXT
Tolterodine and Memory: Dry but Forgetful
Womack and Heilman
Arch Neurol 2003;60:771-773.
ABSTRACT
| FULL TEXT
Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
Lanctôt et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:5-21.
ABSTRACT
| FULL TEXT
Intakes of Dietary Docosahexaenoic Acid Ethyl Ester and Egg Phosphatidylcholine Improve Maze-Learning Ability in Young and Old Mice
Lim and Suzuki
J. Nutr. 2000;130:1629-1632.
ABSTRACT
| FULL TEXT
Donepezil Therapy in Clinical Practice: A Randomized Crossover Study
Greenberg et al.
Arch Neurol 2000;57:94-99.
ABSTRACT
| FULL TEXT
The cholinergic hypothesis of Alzheimer's disease: a review of progress
Francis et al.
J. Neurol. Neurosurg. Psychiatry 1999;66:137-147.
ABSTRACT
| FULL TEXT
Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells
Marino et al.
Proc. Natl. Acad. Sci. USA 1998;95:11465-11470.
ABSTRACT
| FULL TEXT
Prenatal Dietary Choline Supplementation Decreases the Threshold for Induction of Long-Term Potentiation in Young Adult Rats
Pyapali et al.
J. Neurophysiol. 1998;79:1790-1796.
ABSTRACT
| FULL TEXT
Life and Death of Neurons in the Aging Brain
Morrison and Hof
Science 1997;278:412-419.
ABSTRACT
| FULL TEXT
The Effects of Nerve Growth Factor on Spatial Recent Memory in Aged Rats Persist after Discontinuation of Treatment
Frick et al.
J. Neurosci. 1997;17:2543-2550.
ABSTRACT
| FULL TEXT
Neurochemical Effects of 3-[1-(Phenylmethyl)-4-Piperidinyl]-1-(2,3,4,5-Tetrahydro-1H-1-Benzazepin-8-yl)-1-Propanone Fumarate (TAK-147), a Novel Acetylcholinesterase Inhibitor, in Rats
Hirai et al.
J. Pharmacol. Exp. Ther. 1997;280:1261-1269.
ABSTRACT
| FULL TEXT
Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
Levey
Proc. Natl. Acad. Sci. USA 1996;93:13541-13546.
ABSTRACT
| FULL TEXT
Effectiveness and Safety of Velnacrine for the Treatment of Alzheimer's Disease: A Double-blind, Placebo-Controlled Study
Antuono et al.
Arch Intern Med 1995;155:1766-1772.
ABSTRACT
Cholinergic blockade and human information processing: are we asking the right questions?
Rusted
J Psychopharmacol 1994;8:54-59.
ABSTRACT
Pharmacotherapy for Asthma and Chronic Obstructive Pulmonary Disease: Current Thinking, Practices, and Controversies
Skorodin
Arch Intern Med 1993;153:814-828.
ABSTRACT
Blood-brain barrier penetration and in vivo activity of an NGF conjugate
Friden et al.
Science 1993;259:373-377.
ABSTRACT
Further evidence that scopolamine can improve verbal fluency
Dunne et al.
J Psychopharmacol 1993;7:159-163.
ABSTRACT
Risk Factors for Delirium in Hospitalized Elderly
Schor et al.
JAMA 1992;267:827-831.
ABSTRACT
Scopolamine-induced amnesia in humans: lack of effects of the benzodiazepine receptor antagonist {beta}-carboline ZK 93426
Duka et al.
J Psychopharmacol 1992;6:382-388.
ABSTRACT
The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers
Molchan et al.
J Psychopharmacol 1992;6:489-500.
ABSTRACT
A New Assessment Tool for Neuropsychopharmacologic Research: The Computerized Neuropsychological Test Battery
Veroff et al.
J Geriatr Psychiatry Neurol 1991;4:211-217.
ABSTRACT
The effects of scopolamine on retrieval from semantic memory
Lines et al.
J Psychopharmacol 1991;5:234-237.
ABSTRACT
Intracerebroventricular Bethanechol for Alzheimer's Disease: Variable Dose-Related Responses
Read et al.
Arch Neurol 1990;47:1025-1030.
ABSTRACT
Relationship of Normal Serum Vitamin B12 and Folate Levels to Cognitive Test Performance in Subtypes of Geriatric Major Depression
Bell et al.
J Geriatr Psychiatry Neurol 1990;3:98-105.
ABSTRACT
Oral Physostigmine as Treatment for Primary Degenerative Dementia: A Double-Blind Placebo-Controlled Inpatient Trial
Jenike et al.
J Geriatr Psychiatry Neurol 1990;3:13-16.
ABSTRACT
Scopolamine and sustained retrieval from semantic memory
Dunne
J Psychopharmacol 1990;4:13-18.
ABSTRACT
The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers
Wesnes et al.
J Psychopharmacol 1990;4:219-232.
ABSTRACT
A Verbal Memory Test With High Predictive Accuracy for Dementia of the Alzheimer Type
Knopman and Ryberg
Arch Neurol 1989;46:141-145.
ABSTRACT
The Effects of Acute Scopolamine in Geriatric Depression
Newhouse et al.
Arch Gen Psychiatry 1988;45:906-912.
ABSTRACT
Drug-Induced Alzheimerism
Kurlan and Como
Arch Neurol 1988;45:356-357.
ABSTRACT
The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man
Preston et al.
J Psychopharmacol 1988;2:67-79.
ABSTRACT
Anticholinergic Sensitivity in Patients With Dementia of the Alzheimer Type and Age-Matched Controls: A Dose-Response Study
Sunderland et al.
Arch Gen Psychiatry 1987;44:418-426.
ABSTRACT
Differential Patterns of Memory Loss Among Patients With Alzheimer's Disease, Huntington's Disease, and Alcoholic Korsakoff's Syndrome
Moss et al.
Arch Neurol 1986;43:239-246.
ABSTRACT
Aged rats: recovery of motor impairments by intrastriatal nigral grafts
Gage et al.
Science 1983;221:966-969.
ABSTRACT
Alzheimer's disease: a disorder of cortical cholinergic innervation
Coyle et al.
Science 1983;219:1184-1190.
ABSTRACT
Toward an Effective Treatment of Alzheimer's Disease
BLASS and WEKSLER
ANN INTERN MED 1983;98:251-253.
ABSTRACT
Effects of Anticholinergic Drugs on Memory in Parkinson's Disease
Sadeh et al.
Arch Neurol 1982;39:666-667.
ABSTRACT
The cholinergic hypothesis of geriatric memory dysfunction
Bartus et al.
Science 1982;217:408-414.
ABSTRACT
Choline stimulates nicotinic receptors on adrenal medullary chromaffin cells to induce catecholamine secretion
Holz and Senter
Science 1981;214:466-468.
ABSTRACT
Brain acetylcholine synthesis declines with senescence
Gibson et al.
Science 1981;213:674-676.
ABSTRACT
Cognitive Processes in Depression
Weingartner et al.
Arch Gen Psychiatry 1981;38:42-47.
ABSTRACT
Memory and Cognitive Function in the Elderly: A Preliminary Trial of Physostigmine
Drachman and Sahakian
Arch Neurol 1980;37:674-675.
ABSTRACT
Age-related changes in passive avoidance retention: modulation with dietary choline
Bartus et al.
Science 1980;209:301-303.
Physostigmine and recent memory: effects in young and aged nonhuman primates
Bartus
Science 1979;206:1087-1089.
ABSTRACT
Pure Memory Loss With Hippocampal Lesions: A Pneumoencephalographic Study
Muramoto et al.
Arch Neurol 1979;36:54-56.
ABSTRACT
Physostigmine: improvement of long-term memory processes in normal humans
Davis et al.
Science 1978;201:272-274.
ABSTRACT
Human serial learning: enhancement with arecholine and choline impairment with scopolamine
Sitaram et al.
Science 1978;201:274-276.
ABSTRACT
Pheniramine Aminosalicylate Overdosage: Reversal of Delirium and Choreiform Movements With Tacrine Treatment
Mendelson
Arch Neurol 1977;34:313-313.
ABSTRACT
Memory Enhancement After Physostigmine Treatment in the Amnesic Syndrome
Peters and Levin
Arch Neurol 1977;34:215-219.
ABSTRACT
Physostigmine: Its Use in Acute Anticholinergic Syndrome With Antidepressant and Antiparkinson Drugs
Granacher and Baldessarini
Arch Gen Psychiatry 1975;32:375-380.
ABSTRACT
